| Literature DB >> 30965974 |
Daniela Anahí Sánchez-Téllez1,2, Lucía Téllez-Jurado3, Luís María Rodríguez-Lorenzo4,5.
Abstract
The aims of this paper are: (1) to review the current state of the art in the field of cartilage substitution and regeneration; (2) to examine the patented biomaterials being used in preclinical and clinical stages; (3) to explore the potential of polymeric hydrogels for these applications and the reasons that hinder their clinical success. The studies about hydrogels used as potential biomaterials selected for this review are divided into the two major trends in tissue engineering: (1) the use of cell-free biomaterials; and (2) the use of cell seeded biomaterials. Preparation techniques and resulting hydrogel properties are also reviewed. More recent proposals, based on the combination of different polymers and the hybridization process to improve the properties of these materials, are also reviewed. The combination of elements such as scaffolds (cellular solids), matrices (hydrogel-based), growth factors and mechanical stimuli is needed to optimize properties of the required materials in order to facilitate tissue formation, cartilage regeneration and final clinical application. Polymer combinations and hybrids are the most promising materials for this application. Hybrid scaffolds may maximize cell growth and local tissue integration by forming cartilage-like tissue with biomimetic features.Entities:
Keywords: cartilage regeneration; hybrid hydrogels; hybrid scaffolds; polymeric hydrogels; polysaccharides
Year: 2017 PMID: 30965974 PMCID: PMC6418920 DOI: 10.3390/polym9120671
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Common clinical procedure used to heal cartilage injury. Original illustration designed and provided by the authors.
Figure 2Top. How artificial scaffolds try to mimic the anisotropic characteristic in cartilage tissue [33,34]. Reprinted with permission of [33] Sandra Camarero-Espinosa et al. Biomaterials, 74: 42–52. Bottom. Matrix regeneration within a macroporous non-degradable implant for osteochondral defects is not enhanced with partial enzymatic digestion of the surrounding tissue. (A) Environmental scanning electron microscopy of a longitudinal slice taken through the cartilage-bone-implant. The specimen was retrieved at the 1 month post-operative time point. Good integration between the implant and the surrounding bone and articular cartilage was observed. (B) Environmental scanning electron microscopy image of a longitudinal slice taken through the cartilage-bone-implant construct at 3 months. Fibrous encapsulation of the implant is highlighted by arrows. Reprinted with permission of [34] Aaron J. Krych et al. J. Mater. Sci. Mater. Med., 24: 2429–2437.
Scaffolds in clinical and preclinical use for cartilage regeneration.
| Application | Material | Problem-result | Ref. |
|---|---|---|---|
| Nose (dorsal augmentation material in rhinoplasty) | Tissue-engineered chondrocyte PCS (Porcine Cartilage-derived Substance) scaffold construct. | Preliminary animal study: Excellent biocompatibility, neocartilage formation starts. However, it was not confirmed that the constructs contributed to the formation of neocartilage. | [ |
| Knee (subchondral bone) | Osteochondral biomimetic nanostructured scaffold Maioregen® | Better results in healing complex lesions in comparison with the implantation of a purely chondral scaffold. | [ |
| Cell-free biphasic scaffold: collagen-hydroxyapatite osteochondral scaffold | Statistically significant improvement in clinical scores. At 5 years, between 60.9% and 78.3% of the cases showed complete filling of the cartilage, complete integration of the graft, intact repaired tissue surface and homogeneous repaired tissue. | [ | |
| Nanostructured biomimetic three-phasic collagen-hydroxiapatite construct | The implantations to treat chondral and osteochondral knee defects were effective in terms of clinical outcome, although MRI detected abnormal findings. | [ | |
| Knee (chondral defects) | Autologous ovine MNC Cell-seeded and cell-free | The engineered tissue had not local or systemic adverse effects. However, only a poor integration of the tissue engineering product into adjacent tissue was reached and the formed ECM was not mature enough for long-lasting weight-loading resistance. | [ |
| Type I collagen-hydroxyapatite (Maioregen®) nanostructural biomimetic osteochondral scaffold | The use of the Maioregen® scaffold is a good procedure for the treatment of large osteochondral defects; however, the lesion site seems to influence the results. Patient affected in the medial femoral condyle showed better results. | [ | |
| DeNovo (RevaFlex) engineered tissue graft | Preliminary evidence suggests that DeNovo ET implant is capable of spontaneous matrix formation with no immune response, improving function and recreating hyaline-like cartilage. | [ | |
| Knee (femoral condyles) | Biphasic cylindrical osteochondral composite construct of | The regenerated osteochondral tissue was evaluated as a tissue of acceptable quality. | [ |
| Tibial plateau (osteochondral scaffold) | Osteochondral biomimetic collagen-hydroxiapatite scaffold (Maioregen®, Fin-ceramica, Faenza, Italy) | MRI abnormalities. Clinical outcome with stable results up to a mid-term follow-up. | [ |
| Microfractured defect (for filling microfractures) | BioCartilageTM, product containing dehydrated, micronized allogeneic cartilage, implanted with the addition of platelet rich plasma | No human clinical outcomes data available. Data regarding results are limited to expert opinion. | [ |
| Chondroitin sulfate adhesive-Poly(ethylene glycol) diacrylate (PEGDA) hydrogel system combined with standard microfracture surgery | Significant increase in tissue fillers with defects in a short-term follow-up. | [ | |
| Knee (for donor site filling) | Artificial TruFit cylinders made of fully synthetic material called PolyGraft®-Material: 50% copolymer (PDLG), composed of 85% poly( | No clinical improvement could be found. The regeneration of the filled defects took more than 2 years, even though TruFit Plugs are supposed to stimulate cartilage and bone cell migration from the surrounding tissue to the synthetic cylinders. | [ |
| Porous poly(ethylene oxide)terephthalate/butylene terephthalate) (PEOT/PBT) implants | Treated defects did not cause postoperative bleeding. | [ | |
| Shoulder | Engineered hyaluronic acid membrane, Hyalograft® | Using the hyaluronic membrane had no effect on the final outcome. No difference was observed between the fibrocartilage tissue formed after implementing microfractures and the fibrocartilage tissue grown on the hyaluronic acid membrane scaffold. | [ |
Figure 3Chemical and physical crosslinking methods used to form hydrogels.
Figure 4Matrix-based scaffold approaches for cartilage regeneration. Original illustration designed and provided by the authors.
Figure 5Bilayered cartilage scaffold (A) schematized by a diagram illustrating the electrospun fiber zone (FZ) deposited on a particulate-templated foam (PZ). The combination of the two distinct zones is designed to yield an anisotropic scaffold with a smooth articular surface and a more porous region for ECM deposition. (B) Electron microscopy images (top) of the aligned fiber zone that is shared between both scaffold varieties, (middle) the complete bilayered scaffolds with 0.3 mm3 (left) and 1.0 mm3 (right) pores, and (bottom) the sodium chloride porogens used to produce their respective scaffolds. Reprinted with permission from [169] J.A.M. Steele et al. Combinational scaffold morphologies for zonal articular cartilage engineering. Acta Biomaterialia. 10: 2065–2075.
Figure 6Correlation among the multi-scale biomechanical behavior of cartilage tissue. Original illustration designed and provided by the authors.
Figure 7Correlation between current cell-based scaffolds used for cartilage regeneration. Original illustration designed and provided by the authors.
Figure 8Advantages of hybrid gels. From soft mineralized hydrogels to hard compact xerogels. Original illustration designed and provided by the authors.